PRODUCT CAS THERAPEUTIC USE STATUS
Azithromycin Bitterless API 83905-01-05 Antibiotic EDMF Bepotastine API 190786-44-8 Antihistaminic Pipeline Brimonidine API 70359-46-5 Antiglaucoma Pipeline Brinzolamide API 138890-62-7 Antiglaucoma EDMF, JDMF L - Carnosine API 305-84-0 Nutraceutical Development Diacerein API 13739-02-1 Antiarthritic EDMF Dorzolamide API 130693-82-2 Antiglaucoma EDMF Etofenamate API 30544-47-9 Anti-inflammatory EDMF, CEP Febuxostat API 144060-53-7 Antihyperuricemia EDMF Frovatriptan API 158930-17-7 Antimigraine Development Lifitegrast API 1025967-78-5 Dry eye ( DED ) Agent Pipeline Nimodipine API 66085-59-4 Vasodilator cerebral EDMF Nitazoxanide API 55981-09-4 Antihelmintic EDMF Prasugrel API 150322-43-3 Cardiovascular thrombosis Development Ripasudil API 887375-67-9 Antiglaucoma Pipeline Silodosin API 160970-54-7 Prostatic hyperplasia Development
PRODUCT CAS THERAPEUTIC USE STATUS
Bimatoprost HPAPI 155206-00-1 Antiglaucoma DMF Carboprost HPAPI 58551-69-2 Oxytocic Development Fingolimod HPAPI 162359-55-9 Multiple Sclerosis Development Latanoprost HPAPI 130209-82-4 Antiglaucoma EDMF Limaprost HPAPI 74397-12-9 Vasodilator Pipeline Travoprost HPAPI 157283-68-6 Antiglaucoma DMF Tafluprost HPAPI 209860-87-7 Antiglaucoma Pipeline Lubiprostone HPAPI 136790-76-6 IBS Agent Pipeline PRODUCT CAS THERAPEUTIC USE REGULATORY DATA
Azithromycin Bitterless API 83905-01-05 Antibiotic Technical package Brinzolamide USP API 138890-62-7 Antiglaucoma EDMF L - Carnosine API 305-84-0 Nutraceutical Diacerein API 13739-02-1 Antiarthritic EDMF Dorzolamide Hydrochloride USP/EP API 130693-82-2 Antiglaucoma EDMF Duloxetine Hydrochloride API 136434-34-9 Antidepressive Samples available Etofenamate EP API 30544-47-9 Anti-inflammatory EDMF, CEP Febuxostat API 144060-53-7 Antihyperuricemia Samples available Fingolimod API 162359-55-9 Multiple Sclerosis Development Frovatriptan API 158930-17-7 Antimigraine Final R&D Nimodipine USP/EP API 66085-59-4 Vasodilator cerebral EDMF Nitazoxanide API 55981-09-4 Antihelmintic EDMF Pirisudanol API 53659-00-0 Antidepressant EDMF Prasugrel API 150322-43-3 Cardiovascular thrombosis Development Silodosin API 160970-54-7 Prostatic hyperplasia Development
PRODUCT CAS THERAPEUTIC USE REGULATORY DATA
Alprostadil USP HPAPI 745-65-3 Vasodilator Pipeline Bimatoprost HPAPI 155206-00-1 Antiglaucoma Final R&D Carboprost USP Tromethamine salt HPAPI 58551-69-2 Oxytocic R&D Dinoprost HPAPI 38562-01-5 Oxytocic R&D Latanoprost USP HPAPI 130209-82-4 Antiglaucoma EDMF Misoprostol USP HPAPI 59122-46-2 AINS Pipeline Travoprost USP HPAPI 157283-68-6 Antiglaucoma Final R&D Treprostinil HPAPI 81846-19-7 Vasodilator Pipeline